Vaxart, Inc. Gains 34.3%
Fri, Jan 29, 2021 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) jumped higher at $11.98, a gain of 34.3%. The stock appeared on our News Catalysts scanner on Thu 28 Jan 21 at 04:28 PM in the 'BIOTECH' category. From Thu 14 Jan 21, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Tue 11 Aug 20 at $12.49 with a volume of 74M+.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Siebert Financial Corp. (SIEB:NASDAQ), 121.56%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 71.69%
- Catabasis Pharmaceuticals, Inc. (CATB:NASDAQ), 70.78%
- GameStop Corp. (GME:NYSE), 67.87%
- Novavax, Inc. (NVAX:NASDAQ), 64.87%
- AMC Entertainment Holdings, Inc. (AMC:NYSE), 53.65%
- Koss Corporation (KOSS:NASDAQ), 52.53%
- Wah Fu Education Group Limited (WAFU:NASDAQ), 36.44%
- Vaxart, Inc. (VXRT:NASDAQ), 34.3%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 32.72%